Live Breaking News & Updates on Precise Tumor

Stay updated with breaking news from Precise tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Salt Lake City , Salt Lake , South San Francisco , Matt Scalo , Matthew Scalo , Doug Schenkel , Dan Brennan , Puneet Souda , Mychoice Cdx , Mark Verratti , George Daneker , Sam Raha , Paul Diaz , Bracanalysis Cdx , Matt Sykes , Daniel Brennan , Matthew Sykes , Scott Leffler , Wolfe Research , Exchange Commission , National Cancer Center Hospital , Lab Developed , York State Department Of Health , Goldman Sachs ,

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript February 27, 2024 Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $0.02. Myriad Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome […] ....

Salt Lake City , United States , Sam Raha , Matt Scalo , Scott Leffler , Paul Diaz , Genetics Precision Oncology Solutions , Net Promoter Score , Myriad Collaborative , Myriad Genetics Precision Oncology Solutions , South San Francisco , Salt Lake , Precise Tumor , Precise Liquid Tests , Salt Lake City West , Chief Financial , Like Sam , Thanks Scott , Investor Relations , Best Skin , Most Breweries Per , Myriad Genetics , Paul Diaz , Fourth Quarter , Mark Verratti , Matt Scalo ,